Tag Archives: Jayson Bedford

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Integra Lifesciences (NASDAQ: IART), uniQure (NASDAQ: QURE) and Intellia Therapeutics (NASDAQ: NTLA)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Integra Lifesciences (IART – Research Report), uniQure (QURE – Research Report) and Intellia Therapeutics (NTLA – Research Report). Integra Lifesciences (IART) In a

Analysts’ Top Healthcare Picks: AngioDynamics (ANGO), Ocuphire Pharma (OCUP)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AngioDynamics (ANGO – Research Report), Ocuphire Pharma (OCUP – Research Report) and Bluebird Bio (BLUE – Research Report) with bullish sentiments. AngioDynamics

Analysts Offer Insights on Healthcare Companies: Hologic (NASDAQ: HOLX), Millendo Therapeutics (NASDAQ: MLND) and RegenXBio (NASDAQ: RGNX)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Hologic (HOLX – Research Report), Millendo Therapeutics (MLND – Research Report) and RegenXBio (RGNX – Research Report). Hologic (HOLX) Raymond James analyst Jayson Bedford maintained

Integra Lifesciences (IART) Receives a Hold from Raymond James

In a report released yesterday, Jayson Bedford from Raymond James maintained a Hold rating on Integra Lifesciences (IART – Research Report). The company’s shares closed last Wednesday at $60.81. According to TipRanks.com, Bedford is a 5-star analyst with an average

Raymond James Keeps Their Buy Rating on ICU Medical (ICUI)

Raymond James analyst Jayson Bedford maintained a Buy rating on ICU Medical (ICUI – Research Report) today. The company’s shares closed last Wednesday at $205.34. According to TipRanks.com, Bedford is a 5-star analyst with an average return of 15.2% and

Analysts Offer Insights on Healthcare Companies: Dexcom (NASDAQ: DXCM), Infinity Pharma (NASDAQ: INFI) and Orasure Technologies (NASDAQ: OSUR)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Dexcom (DXCM – Research Report), Infinity Pharma (INFI – Research Report) and Orasure Technologies (OSUR – Research Report) with bullish sentiments. Dexcom